Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replication.

Alberto BorghettiG BaldinF LombardiArturo CicculloA CapettiS RusconiG SterrantinoA LatiniM V CossuR GagliardiniA De LucaS Di Giambenedetto

Published in: HIV medicine (2018)

Lamivudine plus dolutegravir was effective in maintaining viral suppression in our cohort and led to an improvement in metabolic and immunologic functions.

Keyphrases

hiv infected patients
antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
hiv aids
sars cov
clinical trial
double blind
hepatitis c virus
study protocol
hiv testing
cross sectional
randomized controlled trial
men who have sex with men
south africa
placebo controlled